Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

Fulcrum Therapeutics (FULC)

Fulcrum Therapeutics Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:FULC
DateTimeSourceHeadlineSymbolCompany
18/06/202421:20Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:FULCFulcrum Therapeutics Inc
18/06/202421:20Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:FULCFulcrum Therapeutics Inc
18/06/202421:20Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:FULCFulcrum Therapeutics Inc
17/06/202421:37Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:FULCFulcrum Therapeutics Inc
13/05/202412:15Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:FULCFulcrum Therapeutics Inc
13/05/202412:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:FULCFulcrum Therapeutics Inc
09/05/202421:10Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:FULCFulcrum Therapeutics Inc
08/03/202423:05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:FULCFulcrum Therapeutics Inc
08/03/202423:00Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:FULCFulcrum Therapeutics Inc
05/03/202421:15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:FULCFulcrum Therapeutics Inc
27/02/202422:18Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:FULCFulcrum Therapeutics Inc
27/02/202422:12Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:FULCFulcrum Therapeutics Inc
27/02/202421:01Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:FULCFulcrum Therapeutics Inc
27/02/202412:01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:FULCFulcrum Therapeutics Inc
31/01/202402:10Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:FULCFulcrum Therapeutics Inc
31/01/202402:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:FULCFulcrum Therapeutics Inc
07/11/202312:05Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:FULCFulcrum Therapeutics Inc
07/11/202312:02Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:FULCFulcrum Therapeutics Inc
02/10/202321:01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:FULCFulcrum Therapeutics Inc
22/08/202312:48Dow Jones NewsFulcrum Therapeutics Shares Rally Premarket as FDA Lifts Study HoldNASDAQ:FULCFulcrum Therapeutics Inc
22/08/202312:01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:FULCFulcrum Therapeutics Inc
11/08/202321:53GlobeNewswire Inc.Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:FULCFulcrum Therapeutics Inc
03/08/202312:11Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:FULCFulcrum Therapeutics Inc
03/08/202312:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:FULCFulcrum Therapeutics Inc
10/07/202322:06Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:FULCFulcrum Therapeutics Inc
07/07/202322:30GlobeNewswire Inc.Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:FULCFulcrum Therapeutics Inc
03/07/202321:16Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:FULCFulcrum Therapeutics Inc
29/06/202321:24Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:FULCFulcrum Therapeutics Inc
29/06/202321:17Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:FULCFulcrum Therapeutics Inc
29/06/202321:17Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:FULCFulcrum Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:FULC